Categories: Wire Stories

Alibaba Group Announces Completion of US$2.65 Billion Offering of U.S. Dollar-denominated Senior Unsecured Notes and RMB17 Billion Offering of RMB-denominated Senior Unsecured Notes

HANGZHOU, China–(BUSINESS WIRE)–Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), “Alibaba,” “Alibaba Group” or the “Company”) today announced (i) the completion of an offering, on November 26, 2024, of US$2.65 billion aggregate principal amount of U.S. dollar-denominated senior unsecured notes, consisting of:

US$1,000,000,000 4.875% notes due 2030 at an issue price per note of 99.838%;

US$1,150,000,000 5.250% notes due 2035 at an issue price per note of 99.649%; and

US$500,000,000 5.625% notes due 2054 at an issue price per note of 99.712% (collectively, the “USD Notes”);

and (ii) the completion of an offering, on November 28, 2024, of RMB17 billion aggregate principal amount of RMB-denominated senior unsecured notes, consisting of:

RMB8,400,000,000 2.65% notes due 2028 at an issue price per note of 100%;

RMB5,000,000,000 2.80% notes due 2029 at an issue price per note of 100%;

RMB2,500,000,000 3.10% notes due 2034 at an issue price per note of 100%; and

RMB1,100,000,000 3.50% notes due 2044 at an issue price per note of 100% (collectively, the “RMB Notes,” and together with the USD Notes, the “Notes”).

The Notes have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws. The USD Notes have been offered and sold in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act and to certain non-U.S. persons in offshore transaction in reliance on Regulation S under the U.S. Securities Act. Alibaba entered into a registration rights agreement in connection with the offering of the USD Notes, under which it agreed to use commercially reasonable efforts to file an exchange offer registration statement to exchange the USD Notes for a new issue of substantially identical debt securities registered under the Securities Act or, under specified circumstances, a shelf registration statement to cover resales of the USD Notes. The RMB Notes have been offered and sold only to certain non-U.S. persons in offshore transaction in reliance on Regulation S under the U.S. Securities Act.

This press release shall not constitute an offer to sell or a solicitation of an offer to purchase any securities, in the United States or elsewhere, and shall not constitute an offer, solicitation or sale of the securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

Contacts

Investor Relations Contact
Lydia Liu

Head of Investor Relations

Alibaba Group Holding Limited

investor@alibaba-inc.com

Media Contacts
Cathy Yan

cathy.yan@alibaba-inc.com

Ivy Ke

ivy.ke@alibaba-inc.com

Alex

Recent Posts

The Best of Both Worlds: Enjoy Authentic, World-Class Deli Meats this Chinese New Year

The "Enjoy the Authentic Joy from Europe" campaign brings the irresistible flavours of renowned deli…

44 minutes ago

Key trading trends to watch in 2025: insights by global broker Octa

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 10 January 2025 - Developments such as…

1 hour ago

Chinachem Group Attains International Recognition for Sustainable Development Efforts

Achieves GRESB Five-Star Rating HONG KONG SAR - Media OutReach Newswire - 10 January 2025…

1 hour ago

Dah Sing Bank and Hong Kong Small and Medium Enterprises Association Join Hands to Support SMEs to Better Understand and Practice ESG

“SME ESG Charter” 2024 enhanced brand image and expanded business opportunities for participating SMEs HONG…

14 hours ago

FEV develops AI-supported driver monitoring system CogniSafe

AACHEN, GERMANY - Newsaktuell - 9 January 2025 - FEV, a leading global innovation driver…

17 hours ago

Top 2 Best Places to Work in Indonesia for 2024 announced

JAKARTA, INDONESIA - Media OutReach Newswire - 9 January 2025 - Novo Nordisk and AstraZeneca…

18 hours ago